Encorafenib

ATC L01EC03 · 11 markets · 21 records

Encorafenib 11 markets · 21 records Forms

AU 5 records · 3 strengths

  • 75 mgcapsuleBRAFTOVIBRAFTOVI encorafenib 75 mg capsule blister pack also in GB·SG·ES +4 unknown
  • 50 mgcapsuleBRAFTOVIBRAFTOVI encorafenib 75 mg capsule blister pack also in GB·SG·ES +1 unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 3 records · 2 strengths

SG 2 records · 2 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

    FR 2 records · 2 strengths

    • 75 mgcapsuleBRAFTOVI 75 mg, gélule also in AU·GB·SG +4
    • 50 mgcapsuleBRAFTOVI 50 m,g gélule also in AU·GB·SG +1

    US 1 records · 1 strengths

    CA 1 records · 1 strengths

    MX 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      TW 1 records · 1 strengths

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.